Insulin aspart, recombinant Subcutaneous and Olaparib Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Olaparib Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: olaparib
Brand name: Lynparza
Synonyms: Olaparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Olaratumab
- Insulin aspart, recombinant Subcutaneous-Olaratumab Intravenous
- Insulin aspart, recombinant Subcutaneous-Oleptro
- Insulin aspart, recombinant Subcutaneous-Oleptro Oral
- Insulin aspart, recombinant Subcutaneous-Olmesartan
- Insulin aspart, recombinant Subcutaneous-Olmesartan and Hydrochlorothiazide
- Olaparib Tablets-Insulin degludec
- Olaparib Tablets-Insulin Degludec (U-100) Prefilled Pens
- Olaparib Tablets-Insulin Degludec (U-100) Vials
- Olaparib Tablets-Insulin Degludec (U-200) Prefilled Pens
- Olaparib Tablets-Insulin degludec and liraglutide
- Olaparib Tablets-Insulin degludec and liraglutide Subcutaneous